Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patients
Convoca: Pfizer, Inc
Termini: 09/04/2026
Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patients
on 2 de març de 2026
with No hi ha comentaris

Deixa un comentari